IFNG and neoplasm: In accordance with this, tumor growth in mice treated with LRAST + RB6-8C5 appeared significantly reduced in the initial treatment phase up to 13 days after tumor inoculation, including the point in time with maximum IFN-γ secretion and covering the timespan of successful MDSC depletion in our experiments—at least regarding PMN-MDSC.